Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
We examined the interplay between the insulin/IGF-1- and beta-catenin-regulated pathways, both of which are suspected to play a role in hepatocarcinogenesis. Insulin and IGF-1 stimulated the transcription of a Lef/Tcf-dependent luciferase reporter gene by 3-4-fold in HepG2 cells. This stimulation was mediated through the activation of phosphatidylinositol 3-kinase (PI 3-K)/Akt and the inhibition of glycogen synthase kinase-3beta (GSK-3beta) since the effects of insulin and IGF-1 were inhibited by dominant-negative mutants of PI 3-K or Akt and an uninhibitable GSK-3beta. Together with inhibiting GSK-3beta, insulin and IGF-1 increased the cytoplasmic levels of beta-catenin. The PI 3-K/Akt/GSK-3beta pathway was not the sole to mediate insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription. The Ras signalling pathway was also required as (i) the stimulatory effects of insulin and IGF-1 were inhibited by dominant-negative Ras or the MEK1 inhibitor PD98059 and (ii) activated Ha-Ras or constitutively active MEK1 synergized with catalytically inactive GSK-3beta to stimulate Lef/Tcf-dependent transcription. This study provides the first evidence that insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades bifurcating downstream of PI 3-K and involving GSK-3beta inhibition and Ras activation. These findings demonstrate for the first time the ability of insulin and IGF-1 to activate the beta-catenin pathway in hepatoma cells and thereby provide new insights into the role of these factors in hepatocarcinogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cross-talk between the Wnt and insulin signaling pathways has been demonstrated in different disorders such as diabetes and cancer49-53.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [52]
Citations
Cites
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529 · cited 2×
“Results are representative of three independent experiments Oncogene zation in Wnt/Wingless signalling (Aberle et al., 1997), we next wished to examine whether insulin- and IGF-1mediated GSK-3b inhibition a ected the level of bcatenin found in the cytoplasm of HepG2 cells.”
BackgroundA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundMECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,017 · cited 1×
“This pathway plays a critical role in development, proliferation and di erentiation (Wodarz and Nusse, 1998).”
BackgroundBinding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422 · cited 1×
“…molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted…”
BackgroundLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · cited 1×
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundFunctional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., & Birchmeier, W. (1998) · Science · doi:10.1126/science.280.5363.596 · Cited by 1,260 · cited 1×
“…coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system…”
BackgroundIkeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,246 · cited 1×
“…et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system (Aberle et al., 1997).”
BackgroundAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“…adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin…”
BackgroundAssociation of the APC Tumor Suppressor Protein with Catenins
Su, L.-K., Vogelstein, B., & Kinzler, K. W. (1993) · Science · doi:10.1126/science.8259519 · Cited by 1,188 · cited 2×
“…mainly at adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al.,…”
Background
Cited by
Items 101–200 of 326
Debiais, F., Lefevre, G. M., Lemonnier, J., Mée, S. L., Lasmoles, F., Mascarelli, F., & Marie, P. J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.032 · Cited by 80
Kim, I. G., Kim, S. Y., Choi, S., Lee, J. H., Kim, K. C., & Cho, E. (2013) · Oncogene · doi:10.1038/onc.2013.373 · Cited by 77
Ip, W., Shao, W., Chiang, Y.-T. A., & Jin, T. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00249.2012 · Cited by 77
“In many other cell lineages, cat/TCF has been shown to serve as an effector for a variety of signaling molecules, including insulin, IGF-I, several peptide hormones that use cAMP as a second messenger, and the lipid metabolite LPA (2, 5, 14, 15, 37).”
BackgroundInfluentialBeurel, E., Kornprobst, M., Eggelpoël, M.-J. B.-V., Ruiz‐Ruiz, C., Cadoret, A., Capeau, J., & Desbois‐Mouthon, C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.001 · Cited by 82
Self-citationMiao, J., Zhang, Y., Chen, S., Zheng, Q., & Guo, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04457-1 · Cited by 80
Kasdagly, M., Radhakrishnan, S., Reddivari, L., Veeramachaneni, D. N. R., & Vanamala, J. (2014) · Nutrition · doi:10.1016/j.nut.2014.02.016 · Cited by 81
Annenkov, A. E. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8081-0 · Cited by 80
“Studies on non-neural cells indicate that some of Wnt target genes are transcriptionally activated by the IGF1R independently of GSK3β inhibition via mechanisms that involve an Akt-independent action of PI3 kinase [116] or the Ras/Raf/MAPK pathway [106].”
BackgroundLee, H. J., Kim, S. R., Oh, Y., Cho, S., Schleimer, R. P., & Lee, Y. C. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0397tr · Cited by 72
Morikawa, T., Kuchiba, A., Lochhead, P., Nishihara, R., Yamauchi, M., Imamura, Y., Liao, X., Qian, Z. R., Ng, K., Chan, A. T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2276 · Cited by 70
Chen, Y., Chen, Z., Chen, L., Zhang, J., Fu, L., Tao, L., Zhang, Y., Hu, X., & Shen, X. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.001 · Cited by 70
The UPS in diabetes and obesity
Wing, S. S. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s6 · Cited by 64
“However, several downstream targets of AKT1 activation have been identified including FRAP (mTOR) [17] and GSK [18], which lead to stimulation of protein [19] and glycogen synthesis, respectively.”
BackgroundCabezas, R., Báez-Jurado, E., Hidalgo‐Lanussa, O., Echeverría, V., Ashrad, G. M., Sahebkar, A., & Barreto, G. E. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1203-9 · Cited by 67
Igotti, M. V., Pospelova, T. V., Nikulenkov, F., Hollander, C. M., Fornace, A. J., & Pospelov, V. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511059200 · Cited by 75
Tumor Viruses and Cell Signaling Pathways: Deubiquitination versus Ubiquitination
Shackelford, J., & Pagano, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5089-5093.2004 · Cited by 67
Secreted WNT antagonists as tumor suppressors: pro and con
Jeffrey, S. R. (2006) · Frontiers in bioscience · doi:10.2741/1952 · Cited by 69
Sawyer, E. J., Hanby, A. M., Poulsom, R., Jeffery, R. E., Gillett, C., Ellis, I. O., Ellis, P., & Tomlinson, I. P. M. (2003) · The Journal of Pathology · doi:10.1002/path.1391 · Cited by 63
The Wnt Antagonist, Dickkopf-1, as a Target for the Treatment of Neurodegenerative Disorders
Caraci, F., Busceti, C. L., Biagioni, F., Aronica, E., Mastroiacovo, F., Cappuccio, I., Battaglia, G., Bruno, V., Caricasole, A., Copani, A., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9710-0 · Cited by 66
Expression of β-catenin is necessary for physiological growth of adult skeletal muscle
Armstrong, D. D., Wong, V. L., & Esser, K. A. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00644.2005 · Cited by 63
Sabeh, M. E., Saha, S. K., Afrin, S., Islam, M. S., & Borahay, M. A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04174-6 · Cited by 67
Kawai, M., Breggia, A., DeMambro, V., Shen, X., CANALIS, E. M., Bouxsein, M., Beamer, W. G., Clemmons, D. R., & Rosen, C. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193334 · Cited by 65
Sun, J., & Jin, T. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.10.010 · Cited by 65
Wang, W., Li, F., Sun, Y. X., Lei, L., Zhou, H., Lei, T., Xia, Y. Y., Verkman, A. S., & Yang, B. (2015) · The FASEB Journal · doi:10.1096/fj.14-260828 · Cited by 62
Sun, J., Khalid, S., Rozakis-Adcock, M., Fantus, I. G., & Jin, T. (2009) · Oncogene · doi:10.1038/onc.2009.167 · Cited by 66
Mohinta, S., Wu, H., Chaurasia, P., & Watabe, K. (2007) · Frontiers in bioscience · doi:10.2741/2368 · Cited by 61
Maurya, N. S., Kushwah, S., Kushwaha, S. K., Chawade, A., & Mani, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-33327-4 · Cited by 70
Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer
Talero, E., Ávila‐Román, J., & Motilva, V. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802083725 · Cited by 61
Boyer, A., Paquet, M., Laguë, M.-N., Hermo, L., & Boerboom, D. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp051 · Cited by 64
Jesmin, J., Rashid, S. M. M., Jamil, H. M., Hontecillas, R., & Bassaganya-Riera, J. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-45 · Cited by 65
Han, L., Yang, Y., Yue, X., Huang, K., Liu, X., Pu, P., Jiang, H., Yan, W., Jiang, T., & Kang, C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.097 · Cited by 57
“…development that promotes transactivation of the T-cell factor (TCF)/lymphoid enhancer factor (LEF) (Liu et al., 2010), can also be stimulated by growth factors such as EGF, hepatocyte growth factor, IGF-I, IGF-II, and insulin (Desbois-Mouthon et al., 2001; Lu et al., 2003; Morali et al., 2001).”
Insulin-like growth factor-I and bone: lessons from mice and men
Kawai, M., & Rosen, C. J. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-1040-6 · Cited by 64
Wang, Z., Jiang, Y., Guan, D., Li, J., Yin, H., Pan, Y., Xie, D., & Chen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072846 · Cited by 62
Wnt-independent beta-catenin transactivation in tumor development.
Lu, Z., & Hunter, T. R. (2004) · PubMed · Cited by 63
BÜTÜNER, B. D., Alapinar, C., Ertunc, N., Gonen‐Korkmaz, C., Yörükoğlu, K., & Korkmaz, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109868 · Cited by 57
Latasa, M. U., Salis, F., Urtasun, R., García‐Irigoyen, O., Elizalde, M., Uriarte, I., Santamaría, M., Feo, F., Pascale, R. M., Prìeto, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052711 · Cited by 59
“In addition, b-catenin signaling can be activated through cross-talks with other signaling pathways deregulated in HCC [26,33,52–54].”
BackgroundAssociations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 61
Pond, A. C., Herschkowitz, J. I., Schwertfeger, K. L., Welm, B. E., Zhang, Y., York, B., Cardiff, R. D., Hilsenbeck, S. G., Perou, C. M., Creighton, C. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4404 · Cited by 60
“Previous studies have shown that the inhibition of glycogen synthase kinase 3 as a consequence of insulin-like growth factor-I/protein kinase B/AKT or ERK-mediated phosphorylation of Ser residues resulted in enhanced β-catenin stabilization (45).”
BackgroundSinnberg, T. W., Makino, E., Krueger, M. A., Velić, A., Maček, B., Rothbauer, U., Groll, N., Poetz, O., Czemmel, S., Niessner, H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.037 · Cited by 57
“One key nodal point is β-catenin, which acts as a transcriptional activator in many signaling pathways, including the Wnt, EGF (Ji et al., 2009), HGF (Purcell et al., 2011), IGF (Desbois-Mouthon et al., 2001), TGF (Zhou, 2011) and cadherin pathways (Benham-Pyle et al., 2015; Zhang et al., 2013).”
BackgroundInfluentialInduction of Homologue of Slimb Ubiquitin Ligase Receptor by Mitogen Signaling
Spiegelman, V. S., Tang, W., Chan, A. M.-L., Igarashi, M., Aaronson, S. A., Sassoon, D. A., Katoh, M., Slaga, T. J., & Fuchs, S. Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204524200 · Cited by 54
WNT signaling and the regulation of ovarian steroidogenesis
Boerboom, D. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s151 · Cited by 63
“AKT phosphorylates GSK3β on Ser-9, inactivating it and thereby leading to an increase in the levels of hypophosphorylated CTNNB1 (58-60).”
BackgroundSexually Dimorphic Fin Regeneration in Zebrafish Controlled by Androgen/GSK3 Signaling
Nachtrab, G. T., Czerwinski, M. J., & Poss, K. D. (2011) · Current Biology · doi:10.1016/j.cub.2011.09.050 · Cited by 56
The Polycystic Kidney Disease-1 Promoter Is a Target of the β-Catenin/T-cell Factor Pathway
Rodova, M., Islam, M. R., Maser, R. L., & Calvet, J. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203570200 · Cited by 62
Wier, E. M., & Garza, L. A. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.10.002 · Cited by 57
Song, L., Li, Y., He, B., & Gong, Y. (2015) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2015.02.001 · Cited by 56
Ma, R., Wang, L., Zhao, B., Liu, C., Liu, H., Zhu, R., Chen, B., Li, L., Zhao, D., Mo, F., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000455936 · Cited by 50
Labrador‐Rached, C. J., Browning, R. T., Braydich‐Stolle, L. K., & Comfort, K. K. (2018) · Journal of Toxicology · doi:10.1155/2018/1367801 · Cited by 51
M2 macrophages promote wound-induced hair neogenesis.
Kasuya, A., Ito, T., & Tokura, Y. (2018) · Journal of dermatological science (Amsterdam) · doi:10.1016/j.jdermsci.2018.05.004 · Cited by 38
Hudelist, G., Wagner, T. M., Rosner, M., Fink-Retter, A., Gschwantler‐Kaulich, D., Czerwenka, K. F., Kroiss, R., Tea, M.-K., Pischinger, K., Köstler, W. J., et al. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0075 · Cited by 53
Altered Mammary Gland Development in Male Rats Exposed to Genistein and Methoxychlor
Wang, X., Bartolucci, E., Fenton, S. E., & Li, Y. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj120 · Cited by 51
“…b-catenin pathways through two independent mechanisms: inhibition of the GSK-3b-associated multiprotein complex and enhancing MAPK (ERK) activities (Desbois-Mouthon et al., 2001). b-Catenin binds to Fcf/Lef1 transcriptional factors and regulates cyclin D1 and other bcatenin-dependent genes that…”
BackgroundTargeting c-Myc, Ras and IGF Cascade to Treat Cancer and Vascular Disorders
de Nigris, F., Balestrieri, M. L., & Napoli, C. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3138 · Cited by 51
Jones, A., Kulozik, P., Ostertag, A., & Herzig, S. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0973 · Cited by 48
“turn phosphorylates and thereby inhibits GSK-3 [109, 110].”
Lu, W.-J., Chua, M., Wei, W., & So, S. K. (2015) · Oncotarget · doi:10.18632/oncotarget.4913 · Cited by 47
Durand, L. H., Vargas, G. E., Mesones, R. V., Baldi, A., Zago, M. P., Fanovich, M. A., Boccaccini, A. R., & Gorustovich, A. A. (2017) · Materials · doi:10.3390/ma10070740 · Cited by 47
Liu, Y., Li, M., Bo, X., Li, T., Ma, L., Zhai, T., & Huang, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061722 · Cited by 62
Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells
Beurel, E., Eggelpoël, M.-J. B.-V., Kornprobst, M., Moritz, S., Delelo, R., Paye, F., Housset, C., & Desbois‐Mouthon, C. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.026 · Cited by 46
Self-citationIntegration of Ras subeffector signaling in TGF-β mediated late stage hepatocarcinogenesis
Fischer, A. N. M., Herrera, B. M., Mikula, M., Proell, V., Fuchs, E., Gotzmann, J., Schulte‐Hermann, R., Beug, H., & Mikulits, W. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi043 · Cited by 49
Safian, D., Bogerd, J., & Schulz, R. W. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.113244 · Cited by 45
Chen, K., Chen, P., Ho, K., Shih, C.-M., Chou, C., Cheng, C., & Lee, C.-C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225913 · Cited by 44
de‐Freitas‐Junior, J. C. M., Carvalho, S., Dias, A. M., Oliveira, P., Cabral, J., Seruca, R., Oliveíra, C., Morgado‐Díaz, J. A., Reis, C. A., & Pinho, S. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081579 · Cited by 48
“described [33].”
Haidari, M., Zhang, W., Willerson, J. T., & Dixon, R. A. F. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-105 · Cited by 45
Resveratrol potentiates grape seed extract induced human colon cancer cell apoptosis
Vanamala, J. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e352 · Cited by 48
“IGF-1 binding to IGF-1R stimulates downstream proliferating pathways such as the PI3K/Akt and Ras signaling resulting in increased human colon cancer cell proliferation (56, 57).”
BackgroundJung, J. K., Kwun, H. J., Lee, J.-O., Arora, P., & Jang, K. L. (2007) · Journal of General Virology · doi:10.1099/vir.0.82836-0 · Cited by 42
Urbanska, K., Trojanek, J., Valle, L. D., Eldeen, M. B., Hofmann, F., García-Echeverría, C., Khalili, K., & Reiss, K. (2006) · Oncogene · doi:10.1038/sj.onc.1210018 · Cited by 47
“GSK3b undergoes a rapid and transient inhibition through site-specific phosphorylation of the serine 9 residue in response to diverse stimuli including NGF, insulin and IGF-I (Cui et al., 1998; Desbois-Mouthon et al., 2001; Arevalo and Chao, 2005).”
BackgroundMechanisms of RAS/β-catenin interactions
Zeller, E., Hammer, K., Kirschnick, M., & Braeuning, A. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1035-3 · Cited by 47
Diabetes, insulin resistance, and asthma: a review of potential links
Wu, T. D. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000738 · Cited by 41
Why diabetes patients are more prone to the development of colon cancer?
Jin, T. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.03.025 · Cited by 41
Insulin Exacerbates Inflammation in Fibroblast-Like Synoviocytes
Qiao, L., Li, Y., & Sun, S. (2020) · Inflammation · doi:10.1007/s10753-020-01178-0 · Cited by 41
Liu, X., Meng, J., Zhang, X., Liang, X., Zhang, F., Zhao, G., & Zhang, T. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13013 · Cited by 40
Anti-Müllerian hormone, β-catenin and Müllerian duct regression
Xavier, F., & Allard, S. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.09.022 · Cited by 44
Targeting Quiescent Tumor Cells via Oxygen and IGF-I Supplementation
Kyle, A. H., Baker, J. H. E., & Minchinton, A. I. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-3059 · Cited by 39
Ortega, F., Pérez‐Sen, R., & Miras‐Portugal, M. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05021.x · Cited by 41
“It is to be emphasized that the IGF-I effect in hepatoma cells (Desbois-Mouthon et al. 2001) and fibroblast growth factor-induced b-catenin stabilization in cortical neurons (Hashimoto et al.”
BackgroundThe loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling
Mao, R., Zou, F., Yang, L., Lin, S., Li, Y., Ma, M., Yin, P., Liang, X., & Liu, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.10.008 · Cited by 37
Pal, I., Rajesh, Y., Banik, P., Dey, G., Dey, K. K., Bharti, R., Naskar, D., Chakraborty, S., Ghosh, S. K., Das, S. K., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.008 · Cited by 38
Igf3 activates β-catenin signaling to stimulate spermatogonial differentiation in zebrafish
Safian, D., Bogerd, J., & Schulz, R. W. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0124 · Cited by 36
The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects
Lu, W., Xiao, W., Xie, W., Fu, X., Pan, L., Jin, H., Yu, Y., Zhang, Y., & Li, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.735374 · Cited by 36
Negi, A., Ramarao, P., & Kumar, R. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557511313050004 · Cited by 33
Graham, N. A., & Asthagiri, A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314055200 · Cited by 36
Velpula, K. K., Dasari, V. R., Tsung, A. J., Gondi, C. S., Klopfenstein, J. D., Mohanam, S., & Rao, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018017 · Cited by 31
Park, S. Y., Lee, Y., Lee, W. S., Park, O. J., & Kim, Y.-M. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-109 · Cited by 31
“Several reports have suggested that IGF-1 increases βcatenin transcription activity through inhibition of the destroyed Axin/APC/GSK3β complex and increases cell proliferation [21].”
BackgroundJi, H., Wang, J., Fang, B., Fang, X., & Lu, Z. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0413-4 · Cited by 34
Insulin signaling mediates neurodegeneration in glioma
Jarabo, P., de Pablo, C., Herranz, H., Martín, F. A., & Casas‐Tintó, S. (2021) · Life Science Alliance · doi:10.26508/lsa.202000693 · Cited by 32
Hsu, M., Chang, H., & Hung, W. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0077 · Cited by 35
“Since GSK-3b may directly phosphorylate b-catenin and induce its degradation via the ubiquitin/proteasome pathway, inhibition of GSK-3b by AKT induces nuclear accumulation of b-catenin and enhancement of TCF/ b-catenin-mediated gene transcription (Desbois-Mouthon et al. 2001, Skurk et al. 2005).”
BackgroundMcCarty, M. F. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.10.041 · Cited by 30
He, H., Ding, F., Li, Y., Luo, A., Chen, H., Wu, C., & Liu, Z. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0419 · Cited by 28
Guo, F., Wang, H., Jiang, M., Yang, Q., Xiang, Q., Zhou, H., Hu, X., Hao, K., Yang, J., Cao, H., et al. (2020) · PubMed · Cited by 28
Went, M., Sud, A., Mills, C., Hyde, A., Culliford, R., Law, P., Vijayakrishnan, J., Gockel, I., Maj, C., Schumacher, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46927-z · Cited by 29
Liu, X., Choi, R. Y., Jawad, S., & Arnold, J. T. (2010) · The Prostate · doi:10.1002/pros.21293 · Cited by 28
“It has been previously suggested that IGF-I induces the accumulation of cytosolic β-catenin via PI3K/Akt; additionally, the IGF-I/Raf/MEK/ERK pathway is required for β-catenin/TCF signaling (β-CTS) [27].”
BackgroundMethodInfluentialFrom pluripotency to forebrain patterning: an in vitro journey astride embryonic stem cells
Lupo, G., Bertacchi, M., Carucci, N., Augusti-Tocco, G., Biagioni, S., & Cremisi, F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1596-1 · Cited by 30
“Regulation of β-catenin via PI3K/AKT signaling, however, appears to be complex and context-dependent [91, 92].”
BackgroundDevi, T. S., Singh, L. P., Hosoya, K., & Terasaki, T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.007 · Cited by 27
Sun, J., Wang, D., & Jin, T. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.12.007 · Cited by 29
Insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and Porcupine
Cabrae, R., Dubuquoy, C., Caüzac, M., Morzyglod, L., Guilmeau, S., Noblet, B., Fève, B., Postic, C., Burnol, A., & Moldes, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61869-4 · Cited by 26
K-ras gene mutation as a predictor of cancer cell responsiveness to metformin
Ma, Y., Guo, F., Wang, W., Shi, H., Li, D., & Wang, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1596 · Cited by 26
Bai, J., Nakamura, H., Ueda, S., Kwon, Y.-W., Tanaka, T., Ban, S., & Yodoi, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403329200 · Cited by 26
Li, T. W. H., Peng, H., Yang, H., Kurniawidjaja, S., Panthaki, P., Zheng, Y., Mato, J. M., & Lu, S. C.-L. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095679 · Cited by 26
“This is consistent with Yamaji et al. (2011), who observed that SAMe activated PP2A.”
BackgroundInfluentialPapadima, E. M., Niola, P., Melis, C., Pisanu, C., Congiu, D., Cruceanu, C., López, J. P., Turecki, G., Ardau, R., Severino, G., et al. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0938-5 · Cited by 25
“Insulin-like growth factor 1 (IGF-1) has been reported to stimulateβ-catenin throughdeactivationofGSK3βmediatedby PI3K/Akt (phosphoinositide 3-kinase/serine-threonine protein kinase) as well (Desbois-Mouthon et al. 2001).”
Chen, J., Debebe, A., Zeng, N., Kopp, J. L., He, L., Sander, M., & Stiles, B. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-90958-1 · Cited by 25
Li, J., Jiang, S., Chen, Y., Ma, R., Chen, J., Qian, S., Shi, Y., Han, Y., Zhang, S., & Kang, Y. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.08.018 · Cited by 25
Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma
Tanaka, S., Sugimachi, K., Maehara, S., Harimoto, N., Shirabe, K., Wands, J. R., & Sugimachi, K. (2002) · Surgery · doi:10.1067/msy.2002.119495 · Cited by 24
Peptide fragment of thymosin β4 increases hippocampal neurogenesis and facilitates spatial memory
Kim, D.-Y., Moon, E., Yi, J. H., Lee, H., Park, S. J., Ryu, Y., Kim, H.-C., Lee, S., & Ryu, J. H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.017 · Cited by 26
Middha, S. K., Goyal, A. K., Faizan, S. A., Sanghamitra, N., Basistha, B. C., & Usha, T. (2013) · Journal of Biosciences · doi:10.1007/s12038-013-9367-y · Cited by 26
“Studies have shown that introducing competitive inhibitors of GSK-3 leads to increased activity of insulin (Desbois-Mouthon et al. 2001).”
BackgroundTargeting the Wnt Pathway in Cancer
Goss, K. H., & Kahn, M. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8023-6 · Cited by 24
Metadata
- Authors
- Desbois-Mouthon, C., Cadoret, A., Blivet-Van Eggelpoël, M.-J., Bertrand, F., Cherqui, G., Perret, C., & Capeau, J.
- Affiliations
- Inserm (FR)
- Venue
- Oncogene
- Published
- 2001-01-11
- Volume
- 20
- Issue
- 2
- Pages
- 252-259
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2069349104
- Cited by
- 321
- References
- 51
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 11 · 2020: 15 · 2019: 14 · 2018: 11 · 2017: 12 · 2016: 5 · 2015: 11 · 2014: 13 · 2013: 25 · 2012: 16
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- insulin, insulin-like growth factor I, β-catenin signaling, GSK-3β inhibition, Ras signaling, PI3K/Akt signaling, MEK1, hepatocarcinogenesis, hepatoma cells, signal transduction
- MeSH terms
- Cell Division, Cytoskeletal Proteins, DNA-Binding Proteins, Enzyme Activation, Enzyme Inhibitors, Flavonoids, Carcinoma, Hepatocellular, Humans, Insulin, Insulin-Like Growth Factor I, Mutation, Proto-Oncogene Proteins, Genes, ras, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Genes, Reporter, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, Glycogen Synthase Kinases, Glycogen Synthase Kinase 3, MAP Kinase Kinase 1, Proto-Oncogene Proteins c-akt, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.